By
Two and a half years after a biological manufacturing company announced its plans to build a facility in Manhattan, there are few answers about when — and if — it’s going to happen, but local and state officials say discussions still are ongoing.
Scorpius, formerly called Scorpion, announced in April 2022 it would construct a $650-million, 500,000-square-foot vaccine and biologic medicine plant on U.S. Highway 24 just east of Manhattan, a facility that would create 500 jobs.
“The state is still at the table,” said Shanna Goodman, executive director of Pottawatomie County Economic Development. “From what I believe, the state is giving them until the end of this year to get their capital in order.”
The post Officials say discussions with Scorpius are ongoing despite lack of movement appeared first on News Radio KMAN.
